name: | Atogepant |
ATC code: | N02CD07 | route: | oral |
n-compartments | 1 |
Atogepant is an orally administered, small-molecule calcitonin gene-related peptide (CGRP) receptor antagonist, used for the preventive treatment of migraine in adults. It is FDA-approved and is currently used in clinical practice for migraine prevention.
Pharmacokinetic parameters observed in healthy adult subjects after single and multiple oral doses.